+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-02-13Number of Pages: 136

Dermatology Diagnostic Devices and Therapeutics Market (Diagnostic Devices - Dermatoscopes (Contact Oil Immersion Dermatoscopes, Cross-polarized Dermatoscopes, and Hybrid Dermatoscopes), Microscopes and Trichoscopes (Multispectral Photoacaustic Microscopy (PAM), Reflectance Confocal Microscopy (RCM), and Raman Spectroscopy), and Imaging Equipment (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, and Optical Coherence Tomography (OCT)); Drug Class - Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants, and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

The high prevalence of skin disorders and conditions has raised alarm bells in the field of dermatology, paving way for a wide range of dermatology diagnostic devices and therapeutics. Skin conditions such as rosacea, eczema, cell carcinoma, acne, psoriasis, dermatitis, and pruritus among others have created several growth opportunities for the uptake of dermatology diagnostic devices and therapeutics. The research report states that the about 30% to 70% of the global population is affected by these conditions. The global market is also likely to be driven by rising investments in the research and development of novel dermatology therapeutics.

In light these observations, the global dermatology diagnostic devices projected to reach a valuation of US$1 bn 2024 from US$0.6 bn in 2014, rising at a CAGR of 6.9% between 2016 and 2024. On the other hand, the therapeutics market is expected to expand at a CAGR of 1.9% to reach a valuation of US$20.1 bn by the end of 2024 from US$17.5 bn in 2014.

Efficiency of Antibacterial Ointments Makes Segment Frontrunner in Global Market

On the basis of product, the global dermatology devices market is segmented into microscopes and trichoscopes, dermatoscopes, and imaging equipment. Analysts expect that the imaging equipment segment will dominate the global market as it is estimated to surge at a CAGR of 7.4% between the forecast period of 2016 and 2024. The imaging equipment is further sub-segmented into X-ray, ultrasound, magnetic resonance imaging (MRI), optical coherence tomography (OCT), and others.

On the other hand, the dermatology therapeutics market is segmented on the basis of drug class into antifungal agents, antibacterial agents, corticosteroids, antiviral agents, biologics, immunosuppressants, and retinoids. The report suggests that the antibacterial drugs segment will lead the global market in the coming years at it rises at a CAGR of 3.3% between 2016 and 2024. The efficiency of these drugs to treat and prevent skin conditions and disorders is expected to fuel their growth in the coming years. Additionally, the growing demand for oral antibiotics and topical antibacterial drugs is also projected to drive this market during the forecast period.

North America Emerges as Leading Geographical Segment with Accessible Healthcare for All

In terms of geography, the global dermatology diagnostic devices and therapeutics market is segmented into Latin America, Asia Pacific, North America, Asia Pacific, the Middle East and Africa, and Europe. Of these, North America is projected to lead the global market as it held a share of 43.8% in the global market 2014. The easy accessibility to healthcare, affordable healthcare, and high awareness about skin diseases and disorders amongst the overall population is projected to drive the regional market. The North America dermatology diagnostic devices and therapeutics market is also see a terrific rise as the region has a strong presence of pharmaceutical companies and excellent reimbursement policies.

Asia Pacific and Europe, on the other hand, are expected to witness a spurt of growth as well. The ever-increasing pool of geriatrics is anticipated to drive these regional markets. Analysts state that Asia Pacific will progress at a CAGR of 2.4% in the global market during the forecast period. The increasing expenditure on healthcare in the emerging economies is expected to be pivotal to this regional market’s growth.

The leading players slated to define the trajectory of the global dermatology diagnostic devices and therapeutics market are Novartis International AG, Dino-Lite Europe/IDCP B.V., Astellas Pharma, Inc., Agfa-Gevaert N.V., Cutera, Inc., Genentech, Galderma S.A., LEO Pharma A/S, Valeant Pharmaceuticals International, Inc., and Michelson Diagnostics Ltd. 

Section - 1 Preface 
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. Research Methodology : Assumptions

Section - 2 Executive Summary: Global Dermatology Diagnostic Devices and Therapeutics Market 
2.1. Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2014–2024 (US$ Mn)
2.2. Global Dermatology Diagnostic Devices Market, by Product, 2015 (US$ Mn)
2.3. Global Dermatology Therapeutics Market, by Drug Class, 2015 (US$ Mn)
2.4. Global Market Share by Geography (Diagnostic Devices), 2015 and 2024 (Value %)
2.5. Global Market Share by Geography (Therapeutics), 2015 and 2024 (Value %)
2.6. Dermatology Diagnostic Devices Market Snapshot
2.7. Dermatology Therapeutics Market Snapshot 

Section-3 Market Overview: Global Dermatology Diagnostic Devices and Therapeutics Market
3.1. Introduction and Market Definition
3.2. Market Dynamics
       3.2.1. Drivers
       3.2.2. Restraints
       3.2.3. Opportunities
3.3. Porter’s five forces analysis
3.4. Company Market Share
       3.4.1. Company Market Share : Dermatology Diagnostic Devices Market (2015)
       3.4.2. Company Market Share : Dermatology Therapeutics Market (2015)
3.5. Market Attractiveness Analysis
       3.5.1. Market Attractiveness Analysis : Dermatology Diagnostic Devices Market
       3.5.2. Market Attractiveness Analysis : Dermatology Therapeutics Market
       3.5.3. Market Attractiveness Analysis : By Geography
3.6. Overview of Skin Diseases

Section-4 Global Dermatology Diagnostic Devices Market Segmentation, By Product
4.1. Introduction 
4.2. Global Dermatology Diagnostic Devices Market, by Product, 2014–2024 (US$ Mn)
4.3. Global Dermatoscope Market Revenue 2014–2024 (US$ Mn)
       4.3.1. Global Dermatoscope Market Revenue, By Product 2014–2024 (US$ Mn)
4.4. Global Dermatology Microscopes and Trichoscopes Market Revenue 2014–2024 (US$ Mn)
       4.4.1. Global Dermatology Microscopes and Trichoscopes Market Revenue, By Product 2014–2024 (US$ Mn)
4.5. Global Dermatology Imaging Equipment Market Revenue 2014–2024 (US$ Mn)
       4.5.1. Global Dermatology Imaging Equipment Market Revenue, By Product 2014–2024 (US$ Mn)

Section-5 Global Dermatology Therapeutics Market Segmentation, By Drug Class
5.1. Introduction
5.2. Global Dermatology Therapeutics Market, by Drug Class, 2014–2024 (US$ Mn)
       5.2.1. Global Antibacterials for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.2. Global Antifungal Agents for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.3. Global Antiviral Agents for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.4. Global Corticosteroids for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.5. Global Retinoids for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.6. Global Immunosuppresants for Dermatology Market Revenue, 2014–2024 (US$ Mn)
       5.2.7. Global Biologics for Dermatology Market Revenue, 2014–2024 (US$ Mn)

Section-6 Market Segmentation – By Pipeline Assessment
6.1. Global Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3
6.2. Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)

Section-7 Global Dermatology Diagnostic Devices and Therapeutics Market Segmentation, By Region
7.1. Overview
       7.1.1. Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2014–2024 (US$ Mn)
       7.1.2. Global Dermatology Therapeutics Market Revenue, by Geography, 2014–2024 (US$ Mn)
7.2. North America Dermatology Diagnostic Devices and Therapeutics Market
       7.2.1. North America Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.2.2. North America Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.2.2.1. North America Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.2.2.2. North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.2.2.3. North America Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.2.3. North America Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.2.4. North America Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.3. Europe Dermatology Diagnostic Devices and Therapeutics Market
       7.3.1. Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.3.2. Europe Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.3.2.1. Europe Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.3.2.2. Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.3.2.3. Europe Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.3.3. Europe Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.3.4. Europe Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.4. Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market
       7.4.1. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.4.2. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.4.2.1. Asia Pacific Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.4.2.2. Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.4.2.3. Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.4.3. Asia Pacific Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.4.4. Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.5. Latin America Dermatology Diagnostic Devices and Therapeutics Market
       7.5.1. Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.5.2. Latin America Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.5.2.1. Latin America Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.5.2.2. Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.5.2.3. Latin America Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.5.3. Latin America Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.5.4. Latin America Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.6. Middle East and North Africa (MENA) Dermatology Diagnostic Devices and Therapeutics Market
       7.6.1. MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.6.2. MENA Dermatology Diagnostic Devices Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.6.2.1. MENA Dermatoscope Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.6.2.2. MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014–2024 (US$ Mn)
                7.6.2.3. MENA Dermatology Imaging Equipment Market Revenue, by Product, 2014–2024 (US$ Mn)
       7.6.3. MENA Dermatology Therapeutics Market Revenue, by Country, 2014–2024 (US$ Mn)
       7.6.4. MENA Dermatology Therapeutics Market Revenue, by Drug Class, 2014–2024 (US$ Mn)
7.7. Rest of the World (ROW) Dermatology Diagnostic Devices and Therapeutics Market
       7.7.1. ROW Dermatology Diagnostic Devices Market Revenue, 2014–2024 (US$ Mn)
       7.7.2. ROW Dermatology Therapeutics Market Revenue, 2014–2024 (US$ Mn)

Section-8 Historical Snapshot and Current Trends

Section-9 Company Profiles
9.1 Agfa-Gevaert N.V.
       9.1.1 Company Overview (HQ, Business Segments, Employee Strength)
       9.1.2 Financial Overview
       9.1.3 Product Portfolio
       9.1.4 Strategic Overview
9.2 Astellas Pharma, Inc. 
       9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.2.2. Financial Overview
       9.2.3. Product Portfolio
       9.2.4. Strategic Overview
9.3 Cutera, Inc. 
       9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.3.2. Financial Overview
       9.3.3. Product Portfolio
       9.3.4. Strategic Overview
9.4 Dino-Lite Europe/IDCP BV. 
       9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.4.2. Product Portfolio
       9.4.3. Strategic Overview
9.5 Galderma S.A. 
       9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.5.2. Financial Overview
       9.5.3. Product Portfolio
       9.5.5. Strategic Overview
9.6 Genentech, a Roche Company 
       9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.6.2. Product Portfolio
       9.6.3. Strategic Overview
9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.) 
       9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.7.2. Financial Overview
       9.7.3. Product Portfolio
       9.7.4. Strategic Overview
9.8 LEO Pharma A/S
       9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.8.2. Financial Overview
       9.8.3. Product Portfolio
       9.8.4. Strategic Overview
9.9 Michelson Diagnostics Ltd.
       9.9.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.9.2. Product Portfolio
       9.9.3. Strategic Overview
9.10 Novartis International AG 
       9.10.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.10.2. Financial Overview
       9.10.3. Product Portfolio
       9.10.4. Strategic Overview
9.11 Valeant Pharmaceuticals International, Inc.
       9.11.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.11.2. Financial Overview
       9.11.3. Product Portfolio
       9.11.4. Strategic Overview
9.12 Canfield Scientific, Inc.
       9.12.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.12.2. Product Portfolio
       9.12.3. Strategic Overview

List of Figures

Figure 01 : Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, by Revenue (US$ Mn), 2014–2024
Figure 02 : Global Dermatology Diagnostic Devices Market, by Product (US$ Mn), 2015
Figure 03 : Global Dermatology Therapeutics Market, by Drug Class (US$ Mn), 2015
Figure 04 : Global Market Share, by Region (Diagnostic Devices) (Value %), 2015 and 2024
Figure 05 : Global Market Share, by Region (Therapeutics), (Value %), 2015 and 2024
Figure 06 : Percentage of Population (U.S., China, Japan, and India) over the age of 65: 1980–2050
Figure 07 : Global Percentage Change in the World’s Population, by Age: 2010–2050
Figure 08 : Market Share Analysis of Key Players, Dermatology Diagnostic Devices Market (%), 2015
Figure 09 : Market Share Analysis of Key Players, Dermatology Therapeutics Market (%), 2015
Figure 10 : Market Attractiveness Analysis, by Device, 2015
Figure 11 : Market Attractiveness Analysis, by Drug Class, 2015
Figure 12 : Market Attractiveness Analysis, by Geography, 2015
Figure 13 : Global Dermatoscopes Market Revenue (US$ Mn), 2014–2024
Figure 14 : Global Microscopes and Trichoscopes Market Revenue (US$ Mn), 2014–2024
Figure 15 : Global Imaging Equipment Market Revenue (US$ Mn), 2014–2024
Figure 16 : Global Antibacterials Market Revenue (US$ Mn), 2014–2024
Figure 17 : Global Antifungal Agents Market Revenue (US$ Mn), 2014–2024
Figure 18 : Global Antiviral Agents Market Revenue (US$ Mn), 2014–2024
Figure 19 : Global Corticosteroids Market Revenue (US$ Mn), 2014–2024
Figure 20 : Global Retinoids Market Revenue (US$ Mn), 2014–2024
Figure 21 : Global Immunosuppressants Market Revenue (US$ Mn), 2014–2024
Figure 22 : Global Biologics Market Revenue (US$ Mn), 2014–2024
Figure 23 : RoW Dermatology Diagnostic Devices Market Revenue, (US$ Mn), 2014–2024
Figure 24 : RoW Dermatology Therapeutics Market Revenue, (US$ Mn), 2014–2024

List of Tables

Table 01 : Global Dermatology Diagnostic Devices Market, by Product, (US$ Mn), 2014–2024
Table 02 : Global Dermatoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
Table 03 : Global Microscopes and Trichoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
Table 04 : Global Imaging Equipment Market Revenue, by Product, (US$ Mn) , 2014–2024
Table 05 : Global Dermatology Therapeutics Market, by Drug Class, (US$ Mn), 2014–2024
Table 06 : Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn) 
Table 07 : Global Dermatology Diagnostic Devices Market Revenue, by Region, (US$ Mn), 2014–2024
Table 08 : Global Dermatology Therapeutics Market Revenue, by Region, (US$ Mn), 2014–2024
Table 09 : North America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 10 : North America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 11 : North America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 12 : North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 13 : North America Dermatology Imaging Equipment Market Revenue, by Product Type, 2014–2024 (US$ Mn)
Table 14 : North America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024 
Table 15 : North America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 16 : Europe Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 17 : Europe Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 18 : Europe Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 19 : Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 20 : Europe Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 21 : Europe Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 22 : Europe Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 23 : APAC Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 24 : Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 25 : Asia Pacific Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 26 : Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 27 : Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 28 : Asia Pacific Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 29 : Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 30 : Latin America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 31 : Latin America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 32 : Latin America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 33 : Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 34 : Latin America Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 35 : Latin America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 36 : Latin America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
Table 37 : MENA Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
Table 38 : MENA Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
Table 39 : MENA Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 40 : MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 41 : MENA Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
Table 42 : MENA Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
Table 43 : MENA Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024

Dermatology Diagnostic Devices and Therapeutics Market: Scope and Methodology

This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global dermatology diagnostic devices and therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global dermatology diagnostic devices and therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of product features of different types of diagnostic devices and therapeutics. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of acute skin conditions, chronic skin conditions, skin infections and other dermatology diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Dermatology Diagnostic Devices and Therapeutics Market: Segmentation

Based on product type, the global dermatology diagnostic devices market has been segmented dermatoscopes, microscopes & trichoscopes, and imaging equipment. These segments are further categorized into sub-segments such as contact oil immersion devices, cross-polarized devices and hybrid devices in dermatoscope segment; multispectral confocal microscope, reflectance confocal microscope, Raman spectroscope, and others in dermatology microscopes and trichoscopes segment; and imaging equipment are sub-segmented into x-ray, magnetic resonance imaging, ultrasound, optical coherence tomography, and others.

Based on the drug class, global dermatology therapeutics market is sub-segmented into antibacterial agents, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppressant, and biologics.

Geographically, the global dermatology diagnostic devices and therapeutics market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, Japan, India, Australia, Brazil, Egypt, Kuwait, Saudi Arabia, and UAE.

Dermatology Diagnostic Devices and Therapeutics Market: Geographical and Competitive Dynamics

The report also profiles major players in the dermatology diagnostic devices and therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc., LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, Valeant Pharmaceuticals International, Inc., Canfield Scientific, Inc.

Global dermatology diagnostic devices and therapeutics market has been segmented as follows:

Global Dermatology Diagnostic Devices Market, by Product Type

  • Dermatoscopes
    • Contact Oil Immersion Dermatoscope
    • Cross-Polarized Dermatoscopes
    • Hybrid Dermatoscope
  • Microscopes and Trichoscopes
    • Multispectral Photoacaustic Microscopy (PAM)
    • Reflectance Confocal Microscopy (RCM)
    • Raman Spectroscopy
    • Others
  • Imaging Equipment
    • X-ray
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound
    • Optical Coherence Tomography (OCT)
    • Others

Global Dermatology Therapeutics Market, by Drug Class

  • Antibacterial Agents
  • Antifungal Agents
  • Antiviral Agents
  • Corticosteroids
  • Retinoids
  • Immunosuppressants
  • Biologics

Global Dermatology Diagnostic Devices and Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa
    • Egypt
    • Kuwait
    • Saudi Arabia
    • UAE
    • Rest of Middle East & North Africa
  • Rest of the World (RoW)


 
 
Back To Top